Literature DB >> 19902838

Streptococcosis in farmed Litopenaeus vannamei: a new emerging bacterial disease of penaeid shrimp.

Ken W Hasson1, Ernesto Matheu Wyld, Yaping Fan, Sonia W Lingsweiller, Stephanie J Weaver, Jinling Cheng, Patricia W Varner.   

Abstract

Presumptive systemic streptococcal infections were detected histologically in farmed Litopenaeus vannamei juveniles submitted from a Latin American country and the bacteria isolated. Characterization work demonstrated that the Gram-positive cocci form chains, grow aerobically and anaerobically, are oxidase- and catalase-negative, non-hemolytic, non-motile, Lancefield Group B positive and PCR positive when amplified with a universal streptococcal primer set. Differing Streptococcus identifications were obtained using API 20 Strep and Biolog systems, the former identifying the isolate as S. uberis and the latter as S. parauberis. Injection of specific pathogen-free (SPF) L. vannamei with the bacteria resulted in 100% mortality by 3 d post-injection with successful recovery of the agent from moribund test shrimp hemolymph samples. The recovered isolate was used in per os and waterborne exposure studies of SPF L. vannamei with mortalities ranging from 40 to 100% and 80 to 100%, respectively. Histologic analysis of 5 to 8 moribund shrimp from each exposure method demonstrated that all contained a severe bacteremia characterized by numerous free cocci within the hemolymph and aggregates of vacuolated hemocytes with notable intravacuolar cocci. This unique lesion type was most pronounced within the lymphoid organ and considered pathodiagnostic for this disease. Experimentally induced lesions were identical to those in naturally infected farmed shrimp and the Streptococcus sp. responsible was re-isolated, fulfilling Koch's postulates. Five freeze/thaw cycles of 10 experimentally infected shrimp were performed over a 2 mo period and the bacteria successfully cultured from all shrimp at each interval. These collective findings describe the first reported case of streptococcosis in marine penaeid shrimp in the Western Hemisphere and indicate that the agent may be disseminated via live or frozen infected shrimp.

Entities:  

Mesh:

Year:  2009        PMID: 19902838     DOI: 10.3354/dao02132

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  5 in total

1.  Addition of Molasses Ameliorates Water and Bio-Floc Quality in Shrimp Pond Water.

Authors:  Yustian Rovi Alfiansah; Jens Harder; Matthew James Slater; Astrid Gärdes
Journal:  Trop Life Sci Res       Date:  2022-03-31

2.  Effects of water recirculation rate on the microbial community and water quality in relation to the growth and survival of white shrimp (Litopenaeus vannamei).

Authors:  Zhao Chen; Zhiqiang Chang; Long Zhang; Yuli Jiang; Hongxing Ge; Xiefa Song; Shibo Chen; Fazhen Zhao; Jian Li
Journal:  BMC Microbiol       Date:  2019-08-19       Impact factor: 3.605

3.  Identification of bacterial community composition in freshwater aquaculture system farming of Litopenaeus vannamei reveals distinct temperature-driven patterns.

Authors:  Yuyi Tang; Peiying Tao; Jianguo Tan; Haizhen Mu; Li Peng; Dandan Yang; Shilu Tong; Lanming Chen
Journal:  Int J Mol Sci       Date:  2014-08-07       Impact factor: 5.923

4.  Effects of a Commercial Microbial Agent on the Bacterial Communities in Shrimp Culture System.

Authors:  Zidan Liu; Linglin Qiuqian; Zhiyuan Yao; Xin Wang; Lei Huang; Jialai Zheng; Kai Wang; Laiguo Li; Demin Zhang
Journal:  Front Microbiol       Date:  2018-10-11       Impact factor: 5.640

5.  Mechanism of the Potential Therapeutic Candidate Bacillus subtilis BSXE-1601 Against Shrimp Pathogenic Vibrios and Multifunctional Metabolites Biosynthetic Capability of the Strain as Predicted by Genome Analysis.

Authors:  Dongdong Wang; Jiahui Li; Guoliang Zhu; Kun Zhao; Wenwen Jiang; Haidong Li; Wenjun Wang; Vikash Kumar; Shuanglin Dong; Weiming Zhu; Xiangli Tian
Journal:  Front Microbiol       Date:  2020-10-26       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.